-
1دورية أكاديمية
المؤلفون: William McCoull (1763365), Scott Boyd (1299897), Martin R. Brown (3368084), Muireann Coen (2022340), Olga Collingwood (10270208), Nichola L. Davies (2187538), Ann Doherty (11230947), Gary Fairley (1629775), Kristin Goldberg (1720258), Elizabeth Hardaker (6158861), Guang He (225824), Edward J. Hennessy (1533484), Philip Hopcroft (1613557), George Hodgson (11384115), Anne Jackson (8446269), Xiefeng Jiang (11384118), Ankur Karmokar (689971), Anne-Laure Lainé (11384121), Nicola Lindsay (3927482), Yumeng Mao (2296621), Roshini Markandu (11384124), Lindsay McMurray (2068162), Neville McLean (2128303), Lorraine Mooney (372137), Helen Musgrove (11384127), J. Willem M. Nissink (7424531), Alexander Pflug (2885099), Venkatesh Pilla Reddy (4270252), Philip B. Rawlins (3622793), Emma Rivers (9015803), Marianne Schimpl (208250), Graham F. Smith (2933100), Sharon Tentarelli (1765276), Jon Travers (818670), Robert I. Troup (11384130), Josephine Walton (8059682), Cheng Wang (102692), Stephen Wilkinson (176023), Beth Williamson (8306304), Jon Winter-Holt (8775911), Dejian Yang (11384133), Yuting Zheng (2176086), Qianxiu Zhu (11384136), Paul D. Smith (361345)
مصطلحات موضوعية: Biochemistry, Medicine, Molecular Biology, Pharmacology, Immunology, Cancer, Infectious Diseases, Space Science, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, Information Systems not elsewhere classified, innate immune response, encoded library screen, >] pyridine series, preclinical mc38 immuno, based compound design, selective dual mer, 2 dual mer, axl kinase inhibitors, imidazo [ 1, probe compound, highly selective, current immuno, axl inhibitors, 2 ‑<, 2 -<, tumor microenvironment, target engagement, reduce lipophilicity, potential way
-
2
المؤلفون: William McCoull (1763365), Scott Boyd (1299897), Martin R. Brown (3368084), Muireann Coen (2022340), Olga Collingwood (10270208), Nichola L. Davies (2187538), Ann Doherty (11230947), Gary Fairley (1629775), Kristin Goldberg (1720258), Elizabeth Hardaker (6158861), Guang He (225824), Edward J. Hennessy (1533484), Philip Hopcroft (1613557), George Hodgson (11384115), Anne Jackson (8446269), Xiefeng Jiang (11384118), Ankur Karmokar (689971), Anne-Laure Lainé (11384121), Nicola Lindsay (3927482), Yumeng Mao (2296621), Roshini Markandu (11384124), Lindsay McMurray (2068162), Neville McLean (2128303), Lorraine Mooney (372137), Helen Musgrove (11384127), J. Willem M. Nissink (7424531), Alexander Pflug (2885099), Venkatesh Pilla Reddy (4270252), Philip B. Rawlins (3622793), Emma Rivers (9015803), Marianne Schimpl (208250), Graham F. Smith (2933100), Sharon Tentarelli (1765276), Jon Travers (818670), Robert I. Troup (11384130), Josephine Walton (8059682), Cheng Wang (102692), Stephen Wilkinson (176023), Beth Williamson (8306304), Jon Winter-Holt (8775911), Dejian Yang (11384133), Yuting Zheng (2176086), Qianxiu Zhu (11384136), Paul D. Smith (361345)
مصطلحات موضوعية: Biochemistry, Medicine, Molecular Biology, Pharmacology, Immunology, Cancer, Infectious Diseases, Space Science, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, Information Systems not elsewhere classified, innate immune response, encoded library screen, >] pyridine series, preclinical mc38 immuno, based compound design, selective dual mer, 2 dual mer, axl kinase inhibitors, imidazo [ 1, probe compound, highly selective, current immuno, axl inhibitors, 2 ‑<, 2 -<, tumor microenvironment, target engagement, reduce lipophilicity, potential way